Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
ADIL

ADIL - Adial Pharmaceuticals Inc Stock Price, Fair Value and News

$1.55-0.01 (-0.64%)
Market Closed

Price Targets

ADIL Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ADIL Price Action

Last 7 days

-2.5%

Last 30 days

-5.5%

Last 90 days

-71.8%

Trailing 12 Months

-91.3%

ADIL RSI Chart

ADIL Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ADIL Valuation

Market Cap

2.2M

Price/Earnings (Trailing)

-0.28

EV/EBITDA

0.46

Price/Free Cashflow

-0.34

MarketCap/EBT

-0.28

ADIL Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

ADIL Fundamentals

ADIL Earnings

Earnings (TTM)

-8.0M

Earnings Growth (Yr)

3.6%

Earnings Growth (Qtr)

-11.29%

ADIL Profitability

Return on Equity

-151.18%

Return on Assets

-119.54%

Free Cashflow Yield

-291.46%

ADIL Investor Care

Shares Dilution (1Y)

274.47%

Diluted EPS (TTM)

-12

About Adial Pharmaceuticals Inc

ADIL
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.
 CEO
 WEBSITEadialpharma.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES16

Adial Pharmaceuticals Inc Frequently Asked Questions

ADIL is the stock ticker symbol of Adial Pharmaceuticals Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Tue Apr 28 2026, market cap of Adial Pharmaceuticals Inc is 2.23 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.